A recent study analyzing the Scientific Registry of Transplant Recipients (SRTR) suggested a combination of total tumor volume (cutoff at 115 cm3) and preoperative AFP level (cutoff at 400 ng/mL) could most efficiently predict recipient survival [23]. This evidence concerns the gene AFP and neoplasm.